[Bisphosphonate treatment against breast cancer with bone metastases].
Kohno
Norio
N
Department of Breast Oncology, Tokyo Medical University.
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000209:etiology* / Q000517:prevention & control*; D005598:Fractures, Spontaneous / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D007568:Jaw; D007674:Kidney Diseases / Q000139:chemically induced; D010010:Osteoclasts / Q000502:physiology; D010020:Osteonecrosis / Q000139:chemically induced; D011788:Quality of Life
D050071:Bone Density Conservation Agents; D004164:Diphosphonates